TICKERNOMICS Sign up
Last Update: 2024-12-27 15:22:46
Bausch & Lomb Corp ( BLCO ) https://www.bausch.com
18.14USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
Canada
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
BLCO
8.04%
SPY
32.66%
BLCO
0.00%
SPY
108.59%
BLCO
0.00%
SPY
302.52%
BLCO
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
6310.04
10610.04
0.22
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-17.15
1.35
0.95
-0.85
0.00
19.01
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
3.60
55.18
11.85
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
1.02
1.09
0.00
Other Earnings and Cash Flow Stats:
Bausch & Lomb Corp ( BLCO ) Net Income TTM ($MM) is -368.00
Bausch & Lomb Corp ( BLCO ) Operating Income TTM ($MM) is 124.00
Bausch & Lomb Corp ( BLCO ) Owners' Earnings Annual ($MM) is 0.00
Bausch & Lomb Corp ( BLCO ) Current Price to Owners' Earnings ratio is 0.00
Bausch & Lomb Corp ( BLCO ) EBITDA TTM ($MM) is 570.00
Bausch & Lomb Corp ( BLCO ) EBITDA Margin is 11.85%
Capital Allocation:
Bausch & Lomb Corp ( BLCO ) has paid 0.00 dividends per share and bought back -3.1 million shares in the past 12 months
Bausch & Lomb Corp ( BLCO ) has increased its debt by 164.0 million USD in the last 12 months
Capital Structure:
Bausch & Lomb Corp ( BLCO ) Interest-bearing Debt ($MM) as of last quarter is 4629
Bausch & Lomb Corp ( BLCO ) Annual Working Capital Investments ($MM) are -256
Bausch & Lomb Corp ( BLCO ) Book Value ($MM) as of last quarter is 6661
Bausch & Lomb Corp ( BLCO ) Debt/Capital as of last quarter is 70%
Other Balance Sheet Stats:
Bausch & Lomb Corp ( BLCO ) has 329 million in cash on hand as of last quarter
Bausch & Lomb Corp ( BLCO ) has 1801 million of liabilities due within 12 months, and long term debt 4629 as of last quarter
Bausch & Lomb Corp ( BLCO ) has 353 common shares outstanding as of last quarter
Bausch & Lomb Corp ( BLCO ) has 0 million USD of preferred stock value
Academic Scores:
Bausch & Lomb Corp ( BLCO ) Altman Z-Score is 0.96 as of last quarter
Bausch & Lomb Corp ( BLCO ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
Bausch & Lomb Corp ( BLCO ) largest shareholder is ICAHN CARL C owning 3500000 shares at 63.49 ($MM) value
SAUNDERS BRENT L(an insider) Bought 32250 shares of Bausch & Lomb Corp ( BLCO ) for the amount of $505067.25 on 2024-08-05
88.49% of Bausch & Lomb Corp ( BLCO ) is held by insiders, and 11.76% is held by institutions
Bausch & Lomb Corp ( BLCO ) went public on 2022-05-06
Other Bausch & Lomb Corp ( BLCO ) financial metrics:
FCF:-58.00
Unlevered Free Cash Flow:-608.00
EPS:0.05
Operating Margin:3.60
Gross Profit Margin:55.18
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:0.24
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Bausch & Lomb Corp ( BLCO ) :
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.